Announcements
The board of directors of the company resolved to request the shareholders to authorize the board of directors to handle private placement of common shares at the Annual General Meeting
Date of the board of directors resolution: May 11, 2018 Types of the private placement: common shares Buyers of the private placement and their relationships with the company: persons stipulated …
Amendment on the announcement for 2018 Annual General Meeting
Date of the board of directors resolution: May 11, 2018 Date for convening the shareholders’ meeting: June 27, 2018 Location for convening the shareholders’ meeting: Masterlink Securities Education and Training …
Announcement of change of accountant due to internal adjustment of the accounting firm
Date of occurrence of the event: May 11, 2018 Name of the original accounting firm and name of the original CPA: PwC Taiwan, Huei-Jin Tseng; PwC Taiwan, Ming-Huei Chang Name …
Announcement based on the procedures for acquisition or disposal of assets
Name of the securities: AP Biosciences Inc. Trading date: Jan 10, 2018 to Apr 20, 2018 Trading volume, unit price, and total monetary amount of the transaction: (1) Acquired on …
FDA Clearance of OBI-3424 IND Application for A Phase I/II Study Targeting AKR1C3 Solid Tumors
Date of occurrence of the event: April 19, 2018 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): Head office Reciprocal shareholding ratios: …
OBI Pharma Inc. to attend Credit Suisse Asian Investment Conference
1. Date of the event: 2018/03/21 2. Time: 08:30:00 TST 3. Location：Conrad Hong Kong 4. Summary: OBI Pharma Inc. to attend Credit Suisse Italy Med Conference 5. Any other matters …
Announcement on the Change of Chief Financial Officer
Type of personnel changed (please enter: spokesperson, acting spokesperson, important operational officer, financial officer, accounting officer, research and development officer, or internal audit officer): Financial Officer Date of occurrence of …
OBI Pharma’s Board of Directors approves the announcement of the Company’s 2017 individual and consolidated financial statements
1. Date of occurrence of the event: 2018/03/09 2. Company name: OBI Pharma, Inc 3. Relationship to the Company (please enter “head office” or “subsidiaries”):Parent 4. Reciprocal shareholding ratios: N/A …
The board of directors have resolved 2017 not to distribute dividends
Date of the board of directors resolution:2018/03/09 Appropriations of earnings in cash dividends to shareholders (NT$ per share):0 Cash dividends distributed from legal reserve and capital reserve to shareholders (NT$ …
The Board of Directors resolved to hold 2018 Annual General Meeting
Date of the board of directors resolution: Mar 09, 2018 Date for convening the shareholders’ meeting: Jun 27, 2018 Location for convening the shareholders’ meeting: Masterlink Securities Education and Training …